American Medical Technologies Inc. (ADLI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2007 | 133.82 Thousand USD | -73.53% |
| 2006 | 505.57 Thousand USD | -28.75% |
| 2005 | 709.55 Thousand USD | -21.9% |
| 2004 | 908.53 Thousand USD | -0.7% |
| 2003 | 914.93 Thousand USD | -70.61% |
| 2002 | 3.11 Million USD | -56.66% |
| 2001 | 7.18 Million USD | 4.14% |
| 2000 | 6.89 Million USD | -30.33% |
| 1999 | 9.9 Million USD | -11.81% |
| 1998 | 11.22 Million USD | 171.87% |
| 1997 | 4.12 Million USD | 28.83% |
| 1996 | 3.2 Million USD | 68.67% |
| 1995 | 1.9 Million USD | 35.71% |
| 1994 | 1.4 Million USD | 0.0% |
| 1993 | 1.4 Million USD | -22.22% |
| 1992 | 1.8 Million USD | -72.73% |
| 1991 | 6.6 Million USD | 112.9% |
| 1990 | 3.1 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2008 Q2 | 137.6 Thousand USD | -7.5% |
| 2008 Q3 | 142.79 Thousand USD | 3.77% |
| 2008 Q1 | 148.75 Thousand USD | 11.15% |
| 2007 Q4 | 133.82 Thousand USD | -38.99% |
| 2007 Q2 | 465.77 Thousand USD | -10.86% |
| 2007 FY | 133.82 Thousand USD | -73.53% |
| 2007 Q1 | 522.51 Thousand USD | 3.35% |
| 2007 Q3 | 219.34 Thousand USD | -52.91% |
| 2006 Q2 | 551.56 Thousand USD | -0.0% |
| 2006 Q3 | 579.41 Thousand USD | 5.05% |
| 2006 FY | 505.57 Thousand USD | -28.75% |
| 2006 Q4 | 505.57 Thousand USD | -12.74% |
| 2006 Q1 | 551.57 Thousand USD | -22.27% |
| 2005 Q2 | 1.05 Million USD | 2.98% |
| 2005 Q1 | 1.02 Million USD | 12.38% |
| 2005 FY | 709.55 Thousand USD | -21.9% |
| 2005 Q4 | 709.55 Thousand USD | -29.45% |
| 2005 Q3 | 1 Million USD | -4.34% |
| 2004 Q4 | 908.53 Thousand USD | -16.89% |
| 2004 Q2 | 988.31 Thousand USD | 10.15% |
| 2004 Q3 | 1.09 Million USD | 10.61% |
| 2004 Q1 | 897.24 Thousand USD | -1.93% |
| 2004 FY | 908.53 Thousand USD | -0.7% |
| 2003 Q1 | 2.5 Million USD | -19.57% |
| 2003 Q3 | 855.57 Thousand USD | -23.24% |
| 2003 Q4 | 914.93 Thousand USD | 6.94% |
| 2003 FY | 914.93 Thousand USD | -70.61% |
| 2003 Q2 | 1.11 Million USD | -55.49% |
| 2002 Q1 | 6.95 Million USD | -3.11% |
| 2002 Q2 | 5.93 Million USD | -14.71% |
| 2002 Q3 | 5.14 Million USD | -13.37% |
| 2002 Q4 | 3.11 Million USD | -39.46% |
| 2002 FY | 3.11 Million USD | -56.66% |
| 2001 Q2 | 6.68 Million USD | -1.93% |
| 2001 Q1 | 6.81 Million USD | -1.17% |
| 2001 Q3 | 7.83 Million USD | 17.22% |
| 2001 Q4 | 7.18 Million USD | -8.34% |
| 2001 FY | 7.18 Million USD | 4.14% |
| 2000 Q4 | 6.89 Million USD | -30.25% |
| 2000 Q1 | 10.15 Million USD | 2.6% |
| 2000 FY | 6.89 Million USD | -30.33% |
| 2000 Q2 | 9.95 Million USD | -1.99% |
| 2000 Q3 | 9.88 Million USD | -0.67% |
| 1999 Q1 | 11.12 Million USD | -0.89% |
| 1999 Q4 | 9.9 Million USD | -8.63% |
| 1999 Q3 | 10.83 Million USD | -3.25% |
| 1999 Q2 | 11.19 Million USD | 0.66% |
| 1999 FY | 9.9 Million USD | -11.81% |
| 1998 Q1 | 5.4 Million USD | 30.87% |
| 1998 FY | 11.22 Million USD | 171.87% |
| 1998 Q4 | 11.22 Million USD | 6.8% |
| 1998 Q3 | 10.51 Million USD | 73.87% |
| 1998 Q2 | 6.04 Million USD | 11.88% |
| 1997 Q3 | 4.88 Million USD | 14.78% |
| 1997 FY | 4.12 Million USD | 28.83% |
| 1997 Q4 | 4.12 Million USD | -15.53% |
| 1997 Q2 | 4.25 Million USD | 2.7% |
| 1997 Q1 | 4.14 Million USD | 29.38% |
| 1996 Q3 | 3.13 Million USD | 72.72% |
| 1996 Q4 | 3.2 Million USD | 2.34% |
| 1996 FY | 3.2 Million USD | 68.67% |
| 1996 Q2 | 1.81 Million USD | 29.5% |
| 1996 Q1 | 1.4 Million USD | -26.32% |
| 1995 FY | 1.9 Million USD | 35.71% |
| 1995 Q4 | 1.9 Million USD | 11.76% |
| 1995 Q1 | 1.1 Million USD | -21.43% |
| 1995 Q2 | 1.4 Million USD | 27.27% |
| 1995 Q3 | 1.7 Million USD | 21.43% |
| 1994 Q4 | 1.4 Million USD | -12.5% |
| 1994 Q2 | 1.6 Million USD | 0.0% |
| 1994 Q1 | 1.6 Million USD | 14.29% |
| 1994 Q3 | 1.6 Million USD | 0.0% |
| 1994 FY | 1.4 Million USD | 0.0% |
| 1993 Q4 | 1.4 Million USD | -12.5% |
| 1993 FY | 1.4 Million USD | -22.22% |
| 1993 Q1 | 1.8 Million USD | 0.0% |
| 1993 Q2 | 2.1 Million USD | 16.67% |
| 1993 Q3 | 1.6 Million USD | -23.81% |
| 1992 Q2 | 3.5 Million USD | -18.6% |
| 1992 Q3 | 2.3 Million USD | -34.29% |
| 1992 Q4 | 1.8 Million USD | -21.74% |
| 1992 FY | 1.8 Million USD | -72.73% |
| 1992 Q1 | 4.3 Million USD | -34.85% |
| 1991 FY | 6.6 Million USD | 112.9% |
| 1991 Q1 | 3 Million USD | -3.23% |
| 1991 Q2 | 3.2 Million USD | 6.67% |
| 1991 Q4 | 6.6 Million USD | 50.0% |
| 1991 Q3 | 4.4 Million USD | 37.5% |
| 1990 Q4 | 3.1 Million USD | 0.0% |
| 1990 FY | 3.1 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ansell Limited | 457.04 Million USD | 99.971% |
| Ansell Limited | 457.9 Million USD | 99.971% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | 99.691% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -379.846% |
| Psykey, Inc. | 49.94 Thousand USD | -167.98% |
| ConvaTec Group Plc | 395.54 Million USD | 99.966% |
| ConvaTec Group Plc | 396.1 Million USD | 99.966% |
| Encision Inc. | 1.4 Million USD | 90.457% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 1539.951% |
| LifePoint, Inc. | 2.3 Million USD | 94.205% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | 94.431% |
| Paradigm Medical Industries, Inc. | 441 Thousand USD | 69.653% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -45.653% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | 86.236% |
| SmileDirectClub, Inc. | 49.87 Million USD | 99.732% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 99.962% |
| SheerVision, Inc. | 339.66 Thousand USD | 60.599% |
| United Health Products, Inc. | 33.59 Thousand USD | -298.324% |
| Vasamed, Inc. | 449.02 Thousand USD | 70.196% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -1464.337% |
| Yubo International Biotech Limited | 322.17 Thousand USD | 58.461% |